Xeloda Tablet
Roll over image to zoom in
Xeloda is a nucleoside metabolic inhibitor with antineoplastic activity indicated for:
- Adjuvant Colon Cancer: Patients with Dukes'C colon cancer.
- Metastatic Colorectal Cancer: First-line as monotherapy when treatment with fluoropyrimidine therapy alone is preferred.
- Metastatic Breast Cancer: In combination with docetaxel after failure of prior anthracycline containing therapy.
- As monotherapy in patients resistant to both paclitaxel and an anthracycline-containing regimen.
Capecitabine is a preparation of Capecitabine, an orally-administered chemotherapeutic agent used in the treatment of cancers. Capecitabine is a prodrug, that is enzymatically converted to fluorouracil (antimetabolite) in the tumour, where it inhibits DNA synthesis and slows growth of tumour tissue.
Additional information
| Unit Price | 222 tk |
|---|---|
| Strip Price | 2,220 tk |
Reviews
There are no reviews yet.